Taysha Gene Therapies, Inc. - Common Stock, par value $0.00001 per share (TSHA)

Q: What does CUSIP 877619106 represent in this 13F holders report?

CUSIP 877619106 is the security identifier for TSHA - Taysha Gene Therapies, Inc. - Common Stock, par value $0.00001 per share used to aggregate holder disclosures.

Q: How many institutions held TSHA - Taysha Gene Therapies, Inc. - Common Stock, par value $0.00001 per share in Q4 2020?

51 institutional investors reported TSHA - Taysha Gene Therapies, Inc. - Common Stock, par value $0.00001 per share for Q4 2020. Use the holders table for investor-level position and value details.

CUSIP: 877619106

Q4 2020 13F Holders as of 31 Dec 2020

Type / Class: Equity / Common Stock, par value $0.00001 per share
Shares outstanding: 285,714,286
Total 13F shares: 17,998,551
Share change: +1,097,379
Total reported value: $475,216,635
Price per share: $26.54
Number of holders: 51
Value change: +$32,037,839
Number of buys: 31
Number of sells: 28

Quarterly Holders Quick Answers

What is CUSIP 877619106?
CUSIP 877619106 identifies TSHA - Taysha Gene Therapies, Inc. - Common Stock, par value $0.00001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q1 2021
Previous quarter: Q3 2020

Recent filing periods for CUSIP 877619106:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of TSHA - Taysha Gene Therapies, Inc. - Common Stock, par value $0.00001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
FMR LLC	13F	Company	1.5%	4,207,574	$90,087,000	—	30 Sep 2020	13F
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO	13F	Company	0.7%	2,000,000	$44,800,000	—	30 Sep 2020	13F
BlackRock Finance, Inc.	13F	Company	0.64%	1,840,567	$41,226,000	—	30 Sep 2020	13F
Artal Group S.A.	13F	Company	0.4%	1,140,882	$25,556,000	—	30 Sep 2020	13F
Casdin Capital, LLC	13F	Company	0.29%	820,440	$18,378,000	—	30 Sep 2020	13F
FRANKLIN RESOURCES INC	13F	Company	0.28%	800,520	$17,932,000	—	30 Sep 2020	13F
SANDS CAPITAL MANAGEMENT, LLC	13F	Company	0.29%	820,440	$17,654,000	—	30 Sep 2020	13F
Alphabet Inc.	13F	Company	0.22%	640,882	$14,356,000	—	30 Sep 2020	13F
TYBOURNE CAPITAL MANAGEMENT (HK) LTD	13F	Company	0.17%	500,000	$11,200,000	—	30 Sep 2020	13F
PERCEPTIVE ADVISORS LLC	13F	Company	0.16%	470,440	$10,538,000	—	30 Sep 2020	13F
TimesSquare Capital Management, LLC	13F	Company	0.15%	417,700	$9,356,000	—	30 Sep 2020	13F
Avidity Partners Management LP	13F	Company	0.14%	392,000	$8,781,000	—	30 Sep 2020	13F
SECTORAL ASSET MANAGEMENT INC	13F	Company	0.13%	373,775	$8,373,000	—	30 Sep 2020	13F
ArrowMark Colorado Holdings LLC	13F	Company	0.11%	326,862	$7,322,000	—	30 Sep 2020	13F
DEERFIELD MANAGEMENT COMPANY, L.P.	13F	Company	0.09%	250,000	$5,600,000	—	30 Sep 2020	13F
CITADEL ADVISORS LLC	13F	Company	0.09%	245,034	$5,489,000	—	30 Sep 2020	13F
Point72 Asset Management, L.P.	13F	Company	0.07%	200,000	$4,480,000	—	30 Sep 2020	13F
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	13F	Company	0.07%	200,000	$4,480,000	—	30 Sep 2020	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.06%	173,257	$3,881,000	—	30 Sep 2020	13F
VR Adviser, LLC	13F	Company	0.04%	107,982	$2,598,000	—	30 Sep 2020	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.03%	78,625	$1,761,000	—	30 Sep 2020	13F
Nantahala Capital Management, LLC	13F	Company	0.03%	75,000	$1,680,000	—	30 Sep 2020	13F
VANGUARD GROUP INC	13F	Company	0.03%	75,000	$1,680,000	—	30 Sep 2020	13F
Monashee Investment Management LLC	13F	Company	0.02%	60,000	$1,344,000	—	30 Sep 2020	13F
Alyeska Investment Group, L.P.	13F	Company	0.02%	50,400	$1,129,000	—	30 Sep 2020	13F
GILDER GAGNON HOWE & CO LLC	13F	Company	0.02%	43,410	$972,000	—	30 Sep 2020	13F
Marshall Wace North America L.P.	13F	Company	0.01%	34,835	$780,000	—	30 Sep 2020	13F
CAAS CAPITAL MANAGEMENT LP	13F	Company	0.01%	30,000	$672,000	—	30 Sep 2020	13F
Pinz Capital Management, LP	13F	Company	0.01%	27,300	$612,000	—	30 Sep 2020	13F
JANE STREET GROUP, LLC	13F	Company	0.01%	23,234	$520,000	—	30 Sep 2020	13F
GSA CAPITAL PARTNERS LLP	13F	Company	0.01%	20,000	$448,000	—	30 Sep 2020	13F
Zimmer Partners, LP	13F	Company	0.01%	20,000	$448,000	—	30 Sep 2020	13F
WELLINGTON MANAGEMENT GROUP LLP	13F	Company	0.01%	16,889	$378,000	—	30 Sep 2020	13F
PARAMETRIC PORTFOLIO ASSOCIATES LLC	13F	Company	0%	13,700	$307,000	—	30 Sep 2020	13F
ExodusPoint Capital Management, LP	13F	Company	0%	13,015	$292,000	—	30 Sep 2020	13F
Maven Securities LTD	13F	Company	0%	11,784	$277,000	—	30 Sep 2020	13F
UBS Group AG	13F	Company	0%	11,000	$247,000	—	30 Sep 2020	13F
Kovitz Investment Group Partners, LLC	13F	Company	0%	10,000	$224,000	—	30 Sep 2020	13F
NORGES BANK	13F	Company	0%	10,000	$224,000	—	30 Sep 2020	13F
PURA VIDA INVESTMENTS, LLC	13F	Company	0%	10,000	$224,000	—	30 Sep 2020	13F
TUDOR INVESTMENT CORP ET AL	13F	Company	0%	9,725	$218,000	—	30 Sep 2020	13F
Point72 Hong Kong Ltd	13F	Company	0%	5,890	$132,000	—	30 Sep 2020	13F
Bullseye Asset Management LLC	13F	Company	0%	1,000	$22,000	—	30 Sep 2020	13F
Legal & General Group Plc	13F	Company	0%	900	$20,000	—	30 Sep 2020	13F
CAPTRUST FINANCIAL ADVISORS	13F	Company	0%	370	$8,000	—	30 Sep 2020	13F
Quantbot Technologies LP	13F	Company	0%	300	$6,000	—	30 Sep 2020	13F

Institutional Holders of Taysha Gene Therapies, Inc. - Common Stock, par value $0.00001 per share (TSHA) as of Q4 2020

As of 31 Dec 2020, Taysha Gene Therapies, Inc. - Common Stock, par value $0.00001 per share (TSHA) was held by 51 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 17,998,551 shares. The largest 10 holders included FMR LLC, BlackRock Inc., UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGMENT CO, Artal Group S.A., SANDS CAPITAL MANAGEMENT, LLC, Casdin Capital, LLC, FRANKLIN RESOURCES INC, Alphabet Inc., TYBOURNE CAPITAL MANAGEMENT (HK) LTD, and PERCEPTIVE ADVISORS LLC. This page lists 51 institutional shareholders reporting positions in this security for the Q4 2020 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q4 2020 vs Q3 2020 Across Filers

Q3 2020 holders

Q4 2020 holders

Holder diff

Investor	Q3 2020 Shares	Q4 2020 Shares	Share Diff	Share Chg %	Q3 2020 Value $	Q4 2020 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.